Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Sep 13 - Sep 18
Beard, 47, had previously sought a GLP-1 prescription, but her doctor "wouldn't even try" to get it approved, assuming her insurance company would reject coverage of the costly medication, she said
Insert the needle at a 90-degree angle straight into the pinched skin
This article reflects information available in July 2026
Review the posted batch details before ordering
Zepbound: Approved for chronic weight management in adults with obesity, or those who are overweight with at least one weight-related comorbidity (such as hypertension or dyslipidemia)
Tirzepatide: dual GIP/GLP-1 receptor agonism Tirzepatide demonstrated that dual incretin receptor agonism could produce greater weight loss than earlier single-receptor approaches
US$ 20.59
US$ 22.21
US$ 20.18
US$ 25.28
US$ 28.29
US$ 22.38
